LATEST NEWS

Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints
San Diego artist Patricia Pauchnick on how she assembled her illustration for the Immune Matters magazine article "How Pandemics End"
The rapid rise in different parts of the world of deadly, more infectious coronavirus variants that share new mutations is leading scientists to ask a critical question
New LJI research could guide the development of more effective cancer immunotherapies
New funding will support high-risk, high-reward projects led by two early-career scientists
Saliva-based COVID-19 screen proves fast, cheap and reliable
La Jolla, CA—Erica Ollmann Saphire, Ph.D., has been appointed President and CEO of La Jolla Institute for Immunology (LJI), the Institute announced today.
Testing for breast and ovarian cancers has come a long way—but at-risk patients still fall through the cracks. LJI scientist Anup Kumar Singh has won funding to learn more about cancer-causing mutations.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
"Clinical staff and non-medical volunteers are happy to be helping out"
LJI releases new COVID-19 vaccine guide